Clinical Trials Browser

Phase 2 × Terminated × Meningeal Carcinomatosis × Clear all

NCT04729348 2025-07-25

Pembrolizumab And Lenvatinib In Leptomeningeal Metastases

Phase 2 Terminated

Meningeal Carcinomatosis

NCT02684071 2020-01-10

Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain Tumors

Phase 2 Terminated

Familial ependymoma, Ependymoma, Medulloblastoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor, Meningeal Carcinomatosis

NCT00523939 2013-06-17

DepoCyt for Active Lymphomatous or Leukemic Meningitis

Phase 2 Terminated

4 enrolled 6 charts

CNSLymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, B-Cell, Meningeal Carcinomatosis

NCT00005812 2013-05-14

Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma

Phase 2 Terminated

Brain Neoplasms, Central Nervous System Neoplasms, Meningeal Carcinomatosis

NCT00830245 2011-07-26

A Study to Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-small Cell Lung Cancer

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Meningeal Carcinomatosis